Ladostigil (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ladostigil" in Serbian language version.

refsWebsite

Global rank Serbian rank

6nih.gov

4^th place

8^th place

6doi.org

2^nd place

4^th place

1harvard.edu

18^th place

28^th place

1archive.org

6^th place

5^th place

1elsevier.com

610^th place

653^rd place

archive.org (Global: 6^th place; Serbian: 5^th place)

Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Weinstock, M.; Bejar, C.; Wang, R. H.; et al. (2000). „TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease”. Journal of Neural Transmission. Supplementum (60): 157—69. ISBN 978-3-211-83537-1. PMID 11205137. doi:10.1007/978-3-7091-6301-6_10.
Weinreb, O.; Mandel, S.; Bar-Am O; et al. (2009). „Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs”. Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics. 6 (1): 163—74. PMC 5084264 . PMID 19110207. doi:10.1016/j.nurt.2008.10.030.
Weinstock M, Luques L, Bejar C, Shoham S (2006). „Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression”. Journal of Neural Transmission. Supplementum (70): 443—6. ISBN 978-3-211-28927-3. PMID 17017566. doi:10.1007/978-3-211-45295-0_67.
Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122 (1): 155—68. Bibcode:2007NYASA1122..155W. PMID 18077571. doi:10.1196/annals.1403.011.
Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.
Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

elsevier.com (Global: 610^th place; Serbian: 653^rd place)

linkinghub.elsevier.com

Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

harvard.edu (Global: 18^th place; Serbian: 28^th place)

adsabs.harvard.edu

Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122 (1): 155—68. Bibcode:2007NYASA1122..155W. PMID 18077571. doi:10.1196/annals.1403.011.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Weinstock, M.; Bejar, C.; Wang, R. H.; et al. (2000). „TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease”. Journal of Neural Transmission. Supplementum (60): 157—69. ISBN 978-3-211-83537-1. PMID 11205137. doi:10.1007/978-3-7091-6301-6_10.
Weinreb, O.; Mandel, S.; Bar-Am O; et al. (2009). „Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs”. Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics. 6 (1): 163—74. PMC 5084264 . PMID 19110207. doi:10.1016/j.nurt.2008.10.030.
Weinstock M, Luques L, Bejar C, Shoham S (2006). „Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression”. Journal of Neural Transmission. Supplementum (70): 443—6. ISBN 978-3-211-28927-3. PMID 17017566. doi:10.1007/978-3-211-45295-0_67.
Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122 (1): 155—68. Bibcode:2007NYASA1122..155W. PMID 18077571. doi:10.1196/annals.1403.011.
Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.
Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

Ladostigil (Serbian Wikipedia)

archive.org (Global: 6th place; Serbian: 5th place)

doi.org (Global: 2nd place; Serbian: 4th place)

elsevier.com (Global: 610th place; Serbian: 653rd place)